Filter Results
:
(268)
Show Results For
-
All HBS Web
(115,190)
- Faculty Publications (268)
Show Results For
-
All HBS Web
(115,190)
- Faculty Publications (268)
- August 2023
- Supplement
Airbus vs. Boeing (N): Air Travel amidst COVID-19 (July 2020)
By: Ramon Casadesus-Masanell and Jordan Mitchell
Casadesus-Masanell, Ramon, and Jordan Mitchell. "Airbus vs. Boeing (N): Air Travel amidst COVID-19 (July 2020)." Harvard Business School Supplement 724-377, August 2023.
- August 2023
- Supplement
Airbus vs. Boeing (O): Aiming towards Carbon-Free Flying (June 2023)
By: Ramon Casadesus-Masanell and Jordan Mitchell
Casadesus-Masanell, Ramon, and Jordan Mitchell. "Airbus vs. Boeing (O): Aiming towards Carbon-Free Flying (June 2023)." Harvard Business School Supplement 724-378, August 2023.
- August 2023
- Supplement
Zurich Insurance (C): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
- August 2023
- Supplement
Zurich Insurance (B): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
- July 2023 (Revised August 2023)
- Case
Zurich Insurance (A): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Feser, Karolin Frankenberger and Ana Procopio Schoen
- June 2023
- Teaching Note
Keroche (A)–(F)
By: Ramon Casadesus-Masanell and Namrata Arora
Teaching Note for HBS Case Nos. 720-390, 720-391, 720-392, 720-393, 720-394, and 720-395.
View Details
- June 2023
- Teaching Note
Oriental Land Co., Ltd. — Tokyo Disney Resort
By: Ramon Casadesus-Masanell and Akiko Kanno
Teaching Note for HBS Case No. 720-460.
View Details
- May 2023 (Revised June 2023)
- Case
Novartis (A): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Care and Treatment;
Business Model;
Leadership;
Pharmaceutical Industry;
Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (A): Reimagining Medicine." Harvard Business School Case 723-443, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (B): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Care and Treatment;
Business Model;
Production;
Business Strategy;
Pharmaceutical Industry
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (B): Reimagining Medicine." Harvard Business School Supplement 723-444, May 2023. (Revised June 2023.)
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,...
View Details
Keywords:
Health Testing and Trials;
Health Care and Treatment;
Business Model;
Problems and Challenges;
Pharmaceutical Industry;
Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- March 2023
- Case
On
By: Ramon Casadesus-Masanell, Karolin Frankenberger and Sascha Mader
Founded in 2010, in just one decade, the Swiss company On had established itself as a main player in global sports footwear and apparel. Based on an unconventional strategy which one of the founders labeled as “obsessively distinct,” On grew its sales with a compound...
View Details
- November 2022
- Supplement
HBS Case Video Bosch eBike
Casadesus-Masanell, Ramon. "HBS Case Video Bosch eBike." Harvard Business School Multimedia/Video Supplement 723-860, November 2022.
- November 2022
- Supplement
How is the e-bike market developing
Casadesus-Masanell, Ramon. "How is the e-bike market developing." Harvard Business School Multimedia/Video Supplement 723-857, November 2022.
- November 2022
- Supplement
What are the lessons learned from the e-bike business for other Bosch divisions
Casadesus-Masanell, Ramon. "What are the lessons learned from the e-bike business for other Bosch divisions." Harvard Business School Multimedia/Video Supplement 723-858, November 2022.
- November 2022
- Supplement
What are the lessons learned to make intrapreneurship successful in a large company
Casadesus-Masanell, Ramon. "What are the lessons learned to make intrapreneurship successful in a large company." Harvard Business School Multimedia/Video Supplement 723-859, November 2022.
- November 2022
- Supplement
What were the internal challenges for a technology company like Bosch
Casadesus-Masanell, Ramon. "What were the internal challenges for a technology company like Bosch." Harvard Business School Multimedia/Video Supplement 723-855, November 2022.
- November 2022
- Supplement
What were the main external barriers to entering the e-bike market
Casadesus-Masanell, Ramon. "What were the main external barriers to entering the e-bike market." Harvard Business School Multimedia/Video Supplement 723-854, November 2022.
- November 2022
- Supplement
Why component supplier and not as a OEM
Casadesus-Masanell, Ramon. " Why component supplier and not as a OEM." Harvard Business School Multimedia/Video Supplement 723-853, November 2022.